SL
GOSS icon

Sentinus LLC’s Gossamer Bio GOSS Stock Holding History

Sentinus LLC’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67K Buy
203
+42
+26% +$938 ﹤0.01% 656
2026
Q1 		$4.22K Buy
+161
New +$20.2K ﹤0.01% 595

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Sentinus LLC's GOSS Position: Q2 2026 in Review

Sentinus LLC increased its Gossamer Bio (GOSS) stake by 26% in Q2 2026, buying an estimated $938 and bringing the position to 203 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #656.

Sentinus LLC first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.22K in Q1 2026. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Sentinus LLC held 203 shares of Gossamer Bio worth $2.67K as of Q2 2026.
  • Sentinus LLC bought 42 Gossamer Bio shares in Q2 2026, an estimated $938.
  • Gossamer Bio made up ﹤0.01% of Sentinus LLC's portfolio in Q2 2026, its #656 holding.
  • Sentinus LLC first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Sentinus LLC's Gossamer Bio position peaked at $4.22K in Q1 2026.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.